130 related articles for article (PubMed ID: 2009945)
21. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
Philip T; Armitage JO; Spitzer G; Chauvin F; Jagannath S; Cahn JY; Colombat P; Goldstone AH; Gorin NC; Flesh M
N Engl J Med; 1987 Jun; 316(24):1493-8. PubMed ID: 3295541
[TBL] [Abstract][Full Text] [Related]
22. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation (ABMT) in poor prognosis diffuse non-Hodgkin's lymphomas (NHL). Report of Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Coser P; Santini G; Rizzoli V; Porcellini A; Chisesi T; Sertoli R; Contu A; Salvagno L; Vinante O; Rossi E
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():164. PubMed ID: 2697432
[No Abstract] [Full Text] [Related]
25. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.
Mills W; Chopra R; McMillan A; Pearce R; Linch DC; Goldstone AH
J Clin Oncol; 1995 Mar; 13(3):588-95. PubMed ID: 7884420
[TBL] [Abstract][Full Text] [Related]
26. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.
Chopra R; Goldstone AH; Pearce R; Philip T; Petersen F; Appelbaum F; De Vol E; Ernst P
J Clin Oncol; 1992 Nov; 10(11):1690-5. PubMed ID: 1403052
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation.
de Kreuk M; Ossenkoppele GJ; Meijer CJ; Huijgens PC
Bone Marrow Transplant; 1996 Jun; 17(6):963-71. PubMed ID: 8807101
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow transplantation in 44 patients with aggressive non-Hodgkin's lymphoma at University "La Sapienza" of Rome.
Capria S; Vignetti M; Proia A; Caruso R; Coppola L; Orsini E; Meloni G
Leuk Lymphoma; 1996 Sep; 23(1-2):147-51. PubMed ID: 9021698
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Jackson GH; Lennard AL; Taylor PR; Carey P; Angus B; Lucraft H; Evans RG; Proctor SJ
Br J Cancer; 1994 Sep; 70(3):501-5. PubMed ID: 7521662
[TBL] [Abstract][Full Text] [Related]
30. Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature.
Meehan KR; Pritchard RS; Leichter JW; Littenberg B; Welch HG
Am J Hematol; 1995 Oct; 50(2):116-23. PubMed ID: 7572990
[TBL] [Abstract][Full Text] [Related]
31. Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point.
Bolwell B; Goormastic M; Andresen S
Bone Marrow Transplant; 1997 Mar; 19(5):443-8. PubMed ID: 9052909
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous mastocytosis after autologous bone marrow transplantation.
Van Hoof A; Criel A; Louwagie A; Vanvuchelen J
Bone Marrow Transplant; 1991 Aug; 8(2):151-3. PubMed ID: 1933058
[TBL] [Abstract][Full Text] [Related]
33. Indications and relative indications for stem cell transplantation in non-Hodgkin's lymphoma.
Stewart FM
Leukemia; 1993 Jul; 7(7):1091-4. PubMed ID: 8100601
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic marrow transplantation in non-Hodgkin's lymphoma.
Copelan EA; Kapoor N; Gibbins B; Tutschka PJ
Bone Marrow Transplant; 1990 Jan; 5(1):47-50. PubMed ID: 2404530
[TBL] [Abstract][Full Text] [Related]
35. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.
van Agthoven M; Vellenga E; Fibbe WE; Kingma T; Uyl-de Groot CA
Eur J Cancer; 2001 Sep; 37(14):1781-9. PubMed ID: 11549432
[TBL] [Abstract][Full Text] [Related]
36. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
[TBL] [Abstract][Full Text] [Related]
37. Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery.
Visani G; Dinota A; Verlicchi F; Bandini G; Ricci P; Motta MR; Rizzi S; Lemoli RM; Poluzzi C; Gherlinzoni F
Bone Marrow Transplant; 1988 Nov; 3(6):599-605. PubMed ID: 2905614
[TBL] [Abstract][Full Text] [Related]
38. [High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
Wu GQ
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):47-51. PubMed ID: 7687533
[TBL] [Abstract][Full Text] [Related]
39. Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
Da WM; Zhong JT; Liu Y; Huang YS; Bai H; Wu XX; Ou YX; Wang CB; Xu SF
Chin Med J (Engl); 1993 Apr; 106(4):277-81. PubMed ID: 8325155
[TBL] [Abstract][Full Text] [Related]
40. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK
J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
